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T

rinucleotide repeat disorders are an umbrella group of genetic diseases
that have been well described clinically for a long time; however, the
scientific community is only beginning to understand their molecular
basis. They are classified in two basic groups depending on the location
of the relevant triplet repeats in a coding or a non-coding region of the genome.
Repeat expansion past a disease-specific threshold results in molecular and cellular
abnormalities that manifest themselves as disease symptoms. Repeat expansion is
postulated to occur via slippage during DNA replication and/or transcriptionmediated DNA repair. Trinucleotide repeat disorders are characterized by genetic
anticipation, which is defined by the increasing severity and earlier onset of a
disease as it is inherited through consecutive generations. Through the analysis of
Huntington’s disease as an example of coding trinucleotide repeat disorder and
Fragile X Syndrome as an example of non-coding trinucleotide repeat disorder,
this work will explore the nature of this devastating group of diseases and the
underlying basic molecular processes that construct them. Despite sharing key
characteristics, these diseases differ significantly in the wide variety of havoc
the repeat expansions can create depending on their location and the nature of
the disrupted function. Understanding of the mechanism and specifics of each
individual disease remains critical for development of proper therapies.
Introduction
Trinucleotide repeat disorders are an umbrella group of genetic diseases that
have been well described clinically for a long time; however, their molecular
basis is still being elucidated. For example, Huntington’s disease (HD), one of
the most widely known diseases associated with trinucleotide repeats, was first
described at the end of the 19th century, whereas the gene associated with this
disorder was not discovered until the mid nineties of the 20th century (Chial,
2008). Currently, all known trinucleotide disorders are classified in two basic
groups depending on the location of the relevant triplet repeats in a coding
or non-coding region of the genome. The genome of a human cell could be
viewed as a sum of the cellular DNA comprising its genetic blueprint. Coding
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regions involve very small fraction of the human genome
that codes for proteins. Protein molecules build most of the
organism structures and function as working horses performing
molecular work that underlies cellular physiology. The vast
majority of human DNA does not code for proteins, thus
comprising non-coding regions involved in orchestrating the
regulation of protein expression. The execution of the genetic
program of the human cell depends on the proper function
of both coding and non-coding regions of the genome. As a
general principle, mutations in coding regions inflict changes
of protein sequence and function, whereas mutations in noncoding regions result in changes in the protein levels in the cell.
Cells that are forced to work with altered or missing proteins
exhibit abnormal physiology which on the organismal level is
observed as disease symptoms.
Trinucleotide repeat disorders associated with coding regions
include Huntington’s disease, Kennedy disease (Spinobulbar
muscular atrophy), Haw-River Syndrome (Dentatorubralpallidoluysian atrophy) and five different types of Spinocerebellar
ataxia. These diseases are also called polyglutamine diseases
since all of them are associated with repeats of CAG triplets,
which code for the amino acid glutamine. The pathology of
all diseases in this group involves pathologies of the nervous
system (Cummings and Zoghbi, 2000).
Non-coding trinucleotide repeat disorders include Fragile X
syndrome (associated with CGG repeats), Fragile XE syndrome
(associated with GCC repeats), Friedreich’s ataxia (associated
with GAA repeats), Myotonic Dystrophy (associated with
CTG repeats), Spinocerebellar ataxia type 8 (associated with
CTG repeats) and Spinocerebellar ataxia type 12 (associated
with CAG repeats). Some of these disorders have been found
to be neurodegenerative (Fragile X syndrome) while others, like
myotonic dystrophy, affect muscle maintenance (Cummings
and Zoghbi, 2000).
Both groups of trinucleotide repeat disorders share common
molecular features and most likely common mechanisms
of repeat extension that are directly connected to the flow
of genetic information in the cell. The DNA as a genetic
blueprint is securely stored in the nucleus of the human cell
and constantly monitored for its integrity. DNA replication,
or DNA copying, takes place only before cellular division, to
ensure that exactly the same genetic information is passed to the
resulting offspring. Since proteins are needed continuously in
the cell and the protein synthesizing machinery resides outside
the nucleus, the genetic code is first copied into messenger
RNA (mRNA) via a process called transcription. mRNAs are
easily transported outside the nucleus and then recognized by
the protein-making machines, the ribosomes, which translate
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the genetic information into proteins. Any changes that
take place in the DNA blueprint such as mutations can be
subsequently traced as changes in RNA and could potentially
affect the integrity of the corresponding proteins.
All trinucleotide repeat disorders are associated with genes
whose natural sequence includes multiple repeats. By their
nature, repeats present a challenge for the cellular machinery
handling the DNA or RNA molecules that contain them. One
can rationalize the challenge by comparing the error rates of
reading a page of repetitive text versus a page of non-repetitive
text. The likelihood of skipping or repeating a line by accident
is much greater for repetitive text than for the non-repetitive
one. Similarly, when DNA repeats are replicated or transcribed,
there is an increased chance of error that will result in change
of the number of repeats. Trinucleotide repeat disorders are
associated with repeat expansion. One proposed mechanism
for the expansion has to do with strand slipping during DNA
replication. Petruska, Hartenstine, and Goodman (1997) conducted experiments with synthetic DNA containing trinucleotide repeats and concluded that repeated sequences promote
slippage via DNA looping. In a region of repeats, separation of
the strands of DNA during replication can cause single-stranded loops of repeats. When the looping takes place in parental
DNA strand, the net result is reduction of the number of the
repeats, simply because the repeats in the loop are skipped and
not copied. If the newly replicating DNA loops out, the net
result is repeat expansion since the repeats in the loop are copied twice. Alternative mechanism involves transcription-mediated DNA repair pathways. Repeated sequences confuse the
transcription machinery, which stalls and activates the DNA
repair systems of the cell that occasionally make an error leading to repeat expansion. It is thought that the DNA slippage
mechanism is prevalent in actively dividing cells, whereas the
transcription-mediated DNA repair mechanism is prevalent in
non-dividing cells, such as neurons, for example. The repeat
expansion can take place in both somatic and germ cells, thus
offering an explanation why the severity of the trinucleotide repeats disorders can sometimes change during the course of the
disease in a particular individual and between generations. As
a consequence of the described molecular events, trinucleotide
repeat disorders share a common phenomenon named genetic
anticipation, which is defined by the increasing severity and
earlier onset of a disease as it is inherited through consecutive
generations.
Through the analysis of Huntington’s disease as an example of
coding trinucleotide repeat disorder and Fragile X Syndrome
as an example of non-coding trinucleotide repeat disorder, this
work will explore the nature of this devastating group of diseases
and the underlying basic molecular processes that construct
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them. Despite sharing key characteristics, such as trinucleotide
repeat expansion and genetic anticipation, these diseases differ
significantly in the wide variety of havoc the repeat expansions
can create depending on their location and the nature of the
disrupted function.
Molecular Mechanisms and Pathology of Huntington’s
Disease
Huntington’s disease (HD) is one of the best known disorders
within the polyglutamine diseases. It is an autosomal dominant
disorder caused by the polyglutamine repeat expansion within
the huntingtin protein (Htt) encoded by the IT15 (interesting
transcript 15) gene located on chromosome 4. Individuals are
affected by HD even if they inherit only a single abnormal
copy of the gene. HD affects 1/10,000 individuals and is
characterized by neurodegeneration. Specifically, it involves the
depletion of neurons and an increased number of glial cells,
primarily in the striatum region of the brain associated with
movement planning, working memory, and decision-making.
Other regions like the cortex, thalamus, and subthalamic
nucleus are also affected (Sadri-Vakili and Cha, 2006). This
atrophy of certain brain regions causes profound effects on
the individual, but not until the fourth or fifth decade of life.
An unfortunate truth of this, however, is that by the time the
disease presents itself in symptoms, the mutated gene has likely
been passed on to the next generation.
The three major types of symptoms associated with Huntington’s are behavioral, motor, and cognitive. The disease presents
itself as a progressive deterioration, usually taking the life of the
affected individual 15-20 years after diagnosis (Longshore and
Tarleton, 1996). Behavioral symptoms are the first to present
themselves in the form of mood changes. Next, motor symptoms begin to occur in the extremities through involuntary
twitching and loss of coordination. In conjunction with the
motor symptoms, cognitive symptoms become more noticeable and complicated tasks become progressively more difficult
to think through. As the disease advances, the severity of these
symptoms becomes more intense to the point that the involuntary movements appear more like a frantic dancing as opposed
to twitching. Changes in mood continue to develop though
some people with HD become more apathetic in regards to
their disease, losing interest in activities they used to enjoy.
And finally, it becomes progressively harder for HD patients to
think clearly as the disease worsens. In late stage HD, patients
lose their involuntary movements and begin to experience rigidity and the lack of ability to move voluntarily at all.
It is well known in HD that the number of repeats is an
important component of the disease. Huntingtin (Htt) is a
natural protein found in numerous areas of the brain of all
BridgEwater State UNIVERSITY

individuals. All of the Htt proteins have the polyglutamine
repeats, but the number of repeats can affect the onset,
progression, and overall severity of the disease (Figure 1). Normal
individuals have between 7-34 CAG repeats. Individuals with
more than 40 repeats develop HD. If the number of repeats
is over 70, a juvenile onset of HD is very likely. It has been
observed in clinical settings that the severity and percentage of
early onset of HD increases as the mutation is passed through

Figure 1. Htt gene structure and relationship to HD pathology.
CAG repeat expansions related to HD are located within the protein-coding
sequence (in gray) of the Htt gene, thus affecting the sequence and the 3D
shape of the protein. In contrast, the regulatory sequences of the Htt gene
(Promoter (designated with P), Terminator (designated with T) and the
UnTranslated Regions at the beginning of the gene (5’UTR) and the end
of the gene (3’UTR)) are unaffected. The severity of the disease is directly
correlated to the number of CAG repeats as depicted by the inverted triangle.

families (Longshore and Tarleton, 1996). There have also been
differences in severity and onset depending on the parent from
which the mutation was inherited. In HD, if the abnormal
allele is inherited from the father, there is an increased risk of
earlier onset, presumably from an expansion that had grown
from the father’s generation to his child’s. It was found that the
alleles involved are more unstable when transmitted through
sperm as opposed to the egg, leading to changes in the number
of repeats expanding through sperm transmission (Longshore
and Tarleton, 1996).
There are several ideas of how glutamine expansion within the
huntingtin protein causes HD. It is important to note, however, that neither mechanism is not fully understood. It has
been proposed that the glutamine repeats cause a change in
function of the Htt gene. For example, the mutant Htt protein
binds to an intracellular protein HAP-1, to which the natural
form of the protein would normally not bind. The HAP-1 protein has been noted to be involved in trafficking of vesicles and
organelles, including mitochondria whose major function is
energy production in the cell. The Htt protein, though found
all throughout the body, is present at high concentrations in
the brain. It is also thought that inefficient energy production
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contributes to HD pathology since HD-related neurodegeneration could be reversed experimentally by treating with drugs
interfering with energy-associated signaling (Varma, H., et al.,
2007). Another idea for the effect the trinucleotide repeats
have on Htt and subsequently the brain has to do with the
way that the expansion affects protein folding, the process by
which proteins adopt their 3D shape. When the Htt protein
is misfolded, it gains a toxic function. The misfolded Htt protein has the potential to interact with nearby proteins that will
cause selective degeneration and neuronal death (Cummings
and Zoghbi, 2000). A second effect of the misfolded proteins is
the potential for the formation of aggregates. The proteins attach to one another and form groups that can affect the nuclear
architecture and the functions that it carries out (Cummings
and Zoghbi, 2000).
Lastly, mutated Htt protein can alter transcription by interfering with histone modifications. Histone molecules are part of
the efficient DNA packing in the cell. Strands of DNA wrap
themselves around histone to become more compact when
genes are not used (transcribed). When DNA needs to be transcribed, the strength of the hold the histone has on the DNA
weakens and the DNA can be more easily accessed to allow the
genetic information to be used to make proteins. When the
mutant Htt interacts with histones, chromatin becomes more
compact, therefore inhibiting necessary transcription (SadriVakili and Cha, 2006). Changes in transcription regulation
in the brain clearly have profound effects on brain function
and degeneration, and they are found frequently in those individuals diagnosed with HD (Sadri-Vakili and Cha, 2006). It
is quite possible that mutant Htt protein inflicts brain damage
via multiple mechanisms since the Htt is a large multifunctional protein in its natural form. Logically, when it does not
work properly, multiple physiological circuits of the cell could
be disrupted.

Figure 2. FMR1 gene structure and relationship to Fragile X pathology.
CGG repeat expansions related to Fragile X syndrome are located within
the regulatory 5’UTR sequence (in white, on the left) of the FMR1 gene,
and do not affect the sequence and the 3D shape of the encoded protein. All
regulatory sequences are labeled as described in the legend of Figure 1. The
severity of the disease is directly correlated to the number of CGG repeats as
depicted by the inverted triangle.
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Molecular Mechanisms and Pathology of Fragile X
Syndrome
Just as the mechanism for HD is speculated upon and not
fully understood, mechanisms for a fellow trinucleotide repeat
disorder, Fragile X Syndrome (FXS), are also the subject of
intensive research. Since FXS was one of the first trinucleotide
disorders to be recognized and studied, the mechanisms are
much better understood. The FXS relevant repeat is located in
the 5’ untranslated region (Figure 2) of the FMR1 (Fragile X
Mental Retardation) gene on the X chromosome (Longshore and
Tarleton, 1996), i.e. no changes in the protein itself are taking
place, rather its amount is being changed. In contrast, the HD
repeat is located in a translated region on chromosome 4, i.e.
the defect alters the encoded protein directly introducing more
glutamines. FXS is an X-linked dominant disorder that is one
of the most commonly inherited forms of mental retardation,
second only to Down syndrome. Since males have only one
X-chromosome and females have two X-chromosomes, the
disease manifests itself differently between males and females.
Males usually display a significant intellectual impairment, but
there is a range of severity. There are several distinctive physical
features for FXS that include a long face, large ears, flat feet,
and hyperflexible joints (National Fragile X Foundation,
2012). In terms of behavioral symptoms, increased aggression,
ADHD-like attention issues, and social anxiety are all common
in males affected by FXS. Males pass the disease only to their
daughters since they are the ones inheriting an X chromosome
from their father, whereas male offspring inherit their father’s
Y chromosome. In contrast, females can pass the disease to
both sons and daughters and display less severe phenotypes
as compared to their male counterparts. The differences in
severity of the phonotype are at least in part associated with
the X chromosome inactivation phenomenon in females.
Each female cell randomly inactivates one X chromosome.
If the inactivated chromosome contains a defective copy of
the FRMP gene, then the cell will appear normal because
the working X chromosome contains a functional copy of
the gene. As a result, female bodies contain a variable mix of
normal and defective cells, leading to a broad range of severity
of the symptoms. Only one third of affected females have a
significant intellectual disability and the behavioral symptoms
are the same, but less severe than those affected males where
all cells in the body have a defective X chromosome (National
Fragile X Foundation, 2012).
FXS affects 1/1,250 males and 1/2,500 females and, like an
HD, there is a range of repeats (Figure 2) that can cause the
disorder (Timchenko and Caskey, 1996). Individuals with
stable repeats that do not display the phenotype of FXS have
repeats ranging from 6-46, and unaffected carriers have 50-200
repeats. The unaffected carriers, who have the coding for the
BridgEwater State UNIVERSITY

premutation, can pass along the expansion to their children.
Those individuals with over 200 repeats in the FMR1 gene will
exhibit the described phenotype. Just like HD, FXS displays
unusual inheritance patterns of the nucleotide expansion. In
addition to genetic anticipation, FXS is characterized with a
parent of origin phenomenon or Sherman Paradox (Timchenko
and Caskey, 1996). When a male with premutation has
children, he passes on the premutation with minimal if any
change in the number of the repeats. If a female passes on
premutation alleles, the section is very likely to expand and
develop into a full mutation resulting in Fragile X syndrome.
This phenomenon is attributed to differences in the processes
of sperm and egg formation (Timchenko and Caskey, 1996).
Some individuals can have the FXS mutation but show no
symptoms, a phenomenon known as incomplete penetrance.
Similar to HD, FXS is associated with a particular gene; FMR1
coding for FMRP, or fragile X mental retardation protein. In
healthy individuals, FMRP is expressed in many tissues in
the body with the highest levels in the neurons of the brain,
testes and ovaries (Timchenko and Caskey, 1996). FMRP is an
RNA-binding protein that shuttles between the nucleus and
the cytoplasm presumably regulating the transport of specific
mRNAs. In addition, FMRP has been found to associate with
ribosomes in the dendritic protrusions of neurons, which
suggests potential role in the translation of mRNAs specific
for this area of the cell. FMRP interacts with several proteins;
however the biological significance of the interactions is not
understood (Cummings and Zoghbi, 2000: National Institutes
of Health: FMR1, 2012).
The accumulation of trinucleotide repeats associated with FXS
results in alteration of the expression of the FMR1 gene leading
to limited or absent fragile X protein production in the cell
proposed to lead to disrupted neuronal communication. Two
mechanisms have been experimentally supported: 1) decreased
efficiency of translation initiation, most likely caused by the
repeats impeding the proper assembly of the ribosome on the
FMR1 mRNA and 2) transcription silencing via methylation
of the DNA region governing FMR1 transcription resulting in
lack of FMR1 mRNA and thus lack of Fragile X protein. The
second mechanism is observed only in patients with more than
200 repeats (Timchenko and Caskey, 1996).
Collectively, both mechanisms result in insufficient levels
of FMRP necessary for proper functioning, thus neuronal
abnormalities and loss are observed and mental retardation
occurs (Cummings and Zoghbi, 2000; Longshore and Tarleton,
1996).
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Do all trinucleotide diseases have a common mechanism?
An interesting comparison has been made between HD
and FXS in terms of the underlying mechanisms. There is a
difference in the way in which the mutation affects the primary
function of those pathways. Fragile X syndrome results from
a reduced level of the FMRP or loss of function; whereas
Huntington’s disease results from changes in function of the
associated protein (Cummings and Zoghbi, 2000; Longshore
and Tarleton, 1996). In HD, the increase of the number of
trinucleotide repeats causes the formation of aggregates and the
acquisition of potentially toxic qualities that cause the neuronal
death noted in the disorder. In FXS, the hypermethylation of
the promoter region on the FMR1 gene causes a decrease in
transcription, reducing the amount of FMRP which is vital
for the proper development of neuronal tissue. It is the loss
of function that causes the phenotype, not a gain in toxic
function, as in the case of HD.
Despite their extensive differences, there have been attempts to
link the trinucleotide repeat disorders together mechanistically.
For example, Kaplan, Itzkovitz, and Shapiro (2007) proposed
a universal mechanism for trinucleotide disorders specifically
referring to the size of the repeat and how that affects the
onset of the disorder. They explained that patients with large
nucleotide repeats are born with all relevant cells having a
copy of the mutation and as the individual grew older, the
toxic effects of the repeat’s misfolding or other behavior within
the body grew progressively in numbers. There is a threshold
for the amount of toxicity that is tolerated before phenotypic
manifestations of the disorder begin to arise, and later in life
with more and more developing due to these disorders, the
phenotype begins to appear at these later points. Those with
a greater number of repeats have a more severe display of the
disorder and an earlier onset. According to their proposed
mechanism, the trinucleotide repeat is more potent when it
is longer and it therefore produces more drastic effects and
quicker presentation. Though this mechanism does match
the progression of HD, FXS is one trinucleotide disorder that
does not manifest in this way. FXS presents itself from birth
and does not progressively get worse. It very well may fit the
mechanisms of other trinucleotide disorders, but one of the
most well known of the group does not fit the proposed “allencompassing” theory. The clinical observations could be very
well explained with the underlying molecular events. Since
Fragile X is caused by lack of functional FMRP, the increase
of the number of repeats will not change the condition simply
because all FMRP has been lost already.
As illustrated through the analysis of two of the most prevalent
disorders, the trinucleotide repeats in both coding and noncoding regions of the genome do share several similarities, but
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are very different mechanistically and phenotypically. They
share the same basic type of molecular defect, but depending
on the location of the trinucleotide repeat, the affected proteins
can gain functionality in some cases, while in others can lose
functionality, both of which can result in neuronal loss and
subsequent symptoms. In addition, the natural functions of
each affected protein are very different and their disruption
results in widely varying abnormalities in cell physiology.
Therefore, it seems unwise to try to offer a universal mechanism
that would incorporate all aspects of the trinucleotide
disorders and lead to development of common strategies for
their management and treatment. Thus, it is highly unlikely
that a universal mechanism would apply to all aspects of the
various trinucleotide diseases solely based on the fact that they
stem from the same type of mutation. Understanding of the
mechanism and specifics of each individual disease remains
critical for development of proper therapies.
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